Correlation Between Puma Biotechnology and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and DiaMedica Therapeutics, you can compare the effects of market volatilities on Puma Biotechnology and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and DiaMedica Therapeutics.
Diversification Opportunities for Puma Biotechnology and DiaMedica Therapeutics
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Puma and DiaMedica is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between Puma Biotechnology and DiaMedica Therapeutics
Given the investment horizon of 90 days Puma Biotechnology is expected to generate 13.89 times less return on investment than DiaMedica Therapeutics. In addition to that, Puma Biotechnology is 1.29 times more volatile than DiaMedica Therapeutics. It trades about 0.02 of its total potential returns per unit of risk. DiaMedica Therapeutics is currently generating about 0.31 per unit of volatility. If you would invest 426.00 in DiaMedica Therapeutics on September 14, 2024 and sell it today you would earn a total of 138.00 from holding DiaMedica Therapeutics or generate 32.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Puma Biotechnology vs. DiaMedica Therapeutics
Performance |
| Timeline |
| Puma Biotechnology |
| DiaMedica Therapeutics |
Puma Biotechnology and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Puma Biotechnology and DiaMedica Therapeutics
The main advantage of trading using opposite Puma Biotechnology and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
| DiaMedica Therapeutics vs. Puma Biotechnology | DiaMedica Therapeutics vs. Iovance Biotherapeutics | DiaMedica Therapeutics vs. Day One Biopharmaceuticals | DiaMedica Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |